-
1Academic Journal
المؤلفون: Theelen, W. S. M. E., Krijgsman, O., Monkhorst, K., Kuilman, T., Peters, D. D. G. C., Cornelissen, S., Ligtenberg, M. A., Willems, S. M., Blaauwgeers, J. L. G., van Noesel, C. J. M., Peeper, D. S., van den Heuvel, M. M., Schulze, K.
المصدر: Theelen , W S M E , Krijgsman , O , Monkhorst , K , Kuilman , T , Peters , D D G C , Cornelissen , S , Ligtenberg , M A , Willems , S M , Blaauwgeers , J L G , van Noesel , C J M , Peeper , D S , van den Heuvel , M M & Schulze , K 2020 , ' Presence of a 34-gene signature is a favorable prognostic marker in squamous non-small cell lung carcinoma ' , Journal of translational medicine , vol. 18 , no. 1 ....
مصطلحات موضوعية: NSCLC, Gene expression, Immunoprofiling, Gene signature, CANCER PATIENTS, IMMUNITY, INNATE
وصف الملف: application/pdf
الاتاحة: https://hdl.handle.net/11370/7db0b5dc-de8d-4f64-b4cd-3605b1e352af
https://research.rug.nl/en/publications/7db0b5dc-de8d-4f64-b4cd-3605b1e352af
https://doi.org/10.1186/s12967-020-02436-3
https://pure.rug.nl/ws/files/156216236/s12967_020_02436_3.pdf
http://www.scopus.com/inward/record.url?scp=85087471255&partnerID=8YFLogxK -
2
المؤلفون: Theelen, W. S. M. E., O. Krijgsman, K. Monkhorst, T. Kuilman, D. D. G. C. Peters, S. Cornelissen, M. A. Ligtenberg, S. M. Willems, J. L. G. Blaauwgeers, C. J. M. Van Noesel, D. S. Peeper, M. M. Van Den Heuvel, K. Schulze
-
3
المؤلفون: Theelen, W. S. M. E., O. Krijgsman, K. Monkhorst, T. Kuilman, D. D. G. C. Peters, S. Cornelissen, M. A. Ligtenberg, S. M. Willems, J. L. G. Blaauwgeers, C. J. M. Van Noesel, D. S. Peeper, M. M. Van Den Heuvel, K. Schulze
مصطلحات موضوعية: respiratory system, respiratory tract diseases
-
4
المؤلفون: Theelen, W. S. M. E., O. Krijgsman, K. Monkhorst, T. Kuilman, D. D. G. C. Peters, S. Cornelissen, M. A. Ligtenberg, S. M. Willems, J. L. G. Blaauwgeers, C. J. M. Van Noesel, D. S. Peeper, M. M. Van Den Heuvel, K. Schulze
مصطلحات موضوعية: biochemical phenomena, metabolism, and nutrition
-
5Academic Journal
المؤلفون: Vries, R de1,2 (AUTHOR) rianne.devries@amc.nl, Muller, M3 (AUTHOR) rianne.devries@amc.nl, Noort, V van der4 (AUTHOR), Theelen, W S M E3 (AUTHOR), Schouten, R D3 (AUTHOR), Hummelink, K3,5 (AUTHOR), Muller, S H6 (AUTHOR), Wolf-Lansdorf, M3 (AUTHOR), Dagelet, J W F1 (AUTHOR), Monkhorst, K5 (AUTHOR), Zee, A H Maitland-van der1 (AUTHOR), Baas, P3 (AUTHOR), Sterk, P J1 (AUTHOR), Heuvel, M M van den3,7 (AUTHOR)
المصدر: Annals of Oncology. Oct2019, Vol. 30 Issue 10, p1660-1666. 7p. 1 Chart, 2 Graphs.
-
6Academic Journal
المؤلفون: Mok, T. S.1 tony@clo.cuhk.edu.hk, Wu, Y.-L.2, Ahn, M.-J.3, Garassino, M. C.4, Kim, H. R.5, Ramalingam, S. S.6, Shepherd, F. A.7, He, Y.8, Akamatsu, H.9, Theelen, W. S. M. E.10, Lee, C. K.11, Sebastian, M.12, Templeton, A.13, Mann, H.13, Marotti, M.13, Ghiorghiu, S.13, Papadimitrakopoulou, V. A.14, Mok, Tony S15 (AUTHOR), Wu, Yi-Long15 (AUTHOR), Ahn, Myung-Ju15 (AUTHOR)
المصدر: New England Journal of Medicine. 2/16/2017, Vol. 376 Issue 7, p629-640. 12p.
مصطلحات موضوعية: *PROTEIN-tyrosine kinases, *LUNG cancer treatment, *GROWTH factors, *DRUG efficacy, *CISPLATIN, *THERAPEUTICS, *ANTINEOPLASTIC agents, *COMPARATIVE studies, *EPIDERMAL growth factor, *HETEROCYCLIC compounds, *LUNG cancer, *LUNG tumors, *RESEARCH methodology, *MEDICAL cooperation, *GENETIC mutation, *PLATINUM, *PROGNOSIS, *RESEARCH, *RESEARCH funding, *EVALUATION research, *RANDOMIZED controlled trials, *CHEMICAL inhibitors, CENTRAL nervous system infections
-
7Academic Journal
المؤلفون: Wu, Y-L1 (AUTHOR), Mok, T S K2 (AUTHOR), Han, J-Y3 (AUTHOR), Ahn, M-J4 (AUTHOR), Delmonte, A5 (AUTHOR), Ramalingam, S S6 (AUTHOR), Kim, S-W7 (AUTHOR), Shepherd, F A8 (AUTHOR), Laskin, J9 (AUTHOR), He, Y10 (AUTHOR), Akamatsu, H11 (AUTHOR), Theelen, W S M E12 (AUTHOR), Su, W-C13 (AUTHOR), John, T14 (AUTHOR), Sebastian, M15 (AUTHOR), Mann, H16 (AUTHOR), Miranda, M16 (AUTHOR), Laus, G17 (AUTHOR), Rukazenkov, Y17 (AUTHOR), Papadimitrakopoulou, V18 (AUTHOR)
المصدر: Annals of Oncology. 2019 Supplement, Vol. 30, pN.PAG-N.PAG. 1p.
مصطلحات موضوعية: *NON-small-cell lung carcinoma, *KINASE inhibitors, *PART-time employment, *STOCK options, *BODY surface area
الشركة/الكيان: ASTRAZENECA PLC AZN, BRISTOL-Myers Squibb Co. 001288497 BMY